elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q27852097-0719FAE1-F65C-4EFD-91DB-1A17EE5698F6
Q27852097-0719FAE1-F65C-4EFD-91DB-1A17EE5698F6
BestRank
Statement
http://www.wikidata.org/entity/statement/Q27852097-0719FAE1-F65C-4EFD-91DB-1A17EE5698F6
Multicenter phase I trial of the mitogen-activated protein kinase 1/2 inhibitor BAY 86-9766 in patients with advanced cancer.
P356
Q27852097-0719FAE1-F65C-4EFD-91DB-1A17EE5698F6
BestRank
Statement
http://www.wikidata.org/entity/statement/Q27852097-0719FAE1-F65C-4EFD-91DB-1A17EE5698F6
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
9ffe13d978725b57423664a95597302c6f13ea51
P356
10.1158/1078-0432.CCR-12-3529
http://www.w3.org/2001/XMLSchema#string
P356
1078-0432.CCR-12-3529